Modeling and Simulation in Development and Regulatory Approval of Chimeric Antigen Receptor T‐Cell Therapies: An Analysis of European Medicines Agency Centralized Procedures From 2018 to 2024
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapies represent a major advancement in oncology. These therapies have demonstrated therapeutic potential, particularly in hematological malignancies where patients have relapsed or are refractory to prior treatments. Despite their promise, the deve...
Sparad:
| Huvudupphov: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Wiley
2026-04-01
|
| Serie: | CPT: Pharmacometrics & Systems Pharmacology |
| Ämnen: | |
| Länkar: | https://doi.org/10.1002/psp4.70213 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|